{"custom_id":"syn4939874","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939874\n\n**Initiative:** Cell Culture\n**Name:** Peggy Wallace\n**Contact Email:** peggyw@mgm.ufl.edu\n**Dates:** 6-1-13 to 5-31-16\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Preclinical Translational models\n&nbsp;\n**Background & Rationale:** Neurofibromas, which are benign Schwann cell tumors, are the hallmark feature in the autosomal dominant condition neurofibromatosis 1 (NF1) and are associated with biallelic loss of NF1 gene function. There is a need for effective therapies for neurofibromas, particularly the larger, plexiform neurofibromas. Tissue culture is an important tool for research. However, it is difficult to derive enriched human Schwann cell cultures, and most enter replicative senescence after 6â€“10 passages, impeding cell-based research in NF1.  We are well-positioned to develop cellular models, and collaborate with a robotics R&D/Lead Optimization group.\n&nbsp;\n**Goals of Project:** To identify (create/characterize) semi-immortalized pNF and normal/heterozygous SC lines with suitable phenotypes, such that these lines can be tested in and transitioned to an HTS environment.\n&nbsp;\n**Specific Aims:** \n (1) To create and characterize (semi)immortal PNF Schwann cell lines and normal /heterozygous Schwann cells and compare to the matched, primary cells\n (2) To identify phenotype(s) and genotype(s) that recapitulate original tumor SCs and distinguishes these from normal and heterozygous SCs\n (3) To work with HTS group in identifying optimal media/single culture conditions, prior to scaling the cell culturing and relevant assays to a high-throughput format\n&nbsp;\n**Impact:** Development of critical and much-needed cellular tool-set for the field of NF1\n&nbsp;\n**CELLS AVAILABLE FOR ORDERING WITH UP TO 100% REIMBURSEMENT OF PURCHASE BY NTAP! ** \nThe cells developed and characterized from this project are NOW AVAILABLE FOR ORDERING from ATCC.  To order cells,  [click here](https://www.atcc.org/search#q=NTAP&sort=relevancy).  Your purchase of these cells is up to 100% REIMBURSABLE  by the Neurofibromatosis Therapeutic Acceleration Program (NTAP)! To learn more about getting a reimbursement for your purchase,  [click here](http://www.n-tap.org/plexiform-neurofibromas/cell-lines/)\n\n\n## Tables for Curation\n1. ID: syn51199735\nName: NFOSI-WES-To-Process-2024-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Sara Gosline, Xindi Guo\n- Example files present: 69239-0209702975.bam, 69240-0209702974.bam, 69241-0209702973.bam, 69242-0209702972.bam, 69244-0209702964.bam\n\n\n\n2. ID: syn52386280\nName: Selected pNF cell line Kallisto output\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Sara Gosline\n- Example files present: C856CANXX_1_RNASeq_Kallisto_grch38_quants.tsv, C856CANXX_2_RNASeq_Kallisto_grch38_quants.tsv, C8581ANXX_6_RNASeq_Kallisto_grch38_quants.tsv, C8581ANXX_8_RNASeq_Kallisto_grch38_quants.tsv, C8581ANXX_7_RNASeq_Kallisto_gencodev24_quants.tsv\n\n\n\n3. ID: syn29542257\nName: pNF Cell Line RNA-seq (NFOSIprocessing-2022-04-18)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 11\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Plexiform Neurofibroma, \n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: C856CANXX_1_0_1.fastq.gz, C856CANXX_1_0_2.fastq.gz, C856CANXX_2_0_1.fastq.gz, C856CANXX_2_0_2.fastq.gz, C856CANXX_3_0_1.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn8016650","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn8016650\n\n##TRAPping the metabolic adaptations of plexiform neurofibroma\n**Initiative:** Open\n&nbsp;\n**Names:** Giorgio Colombo, Ph.D.; Andrea Rasola, Ph.D., M.S.\n**Contact Email:** giorgio.colombo@gmail.com; andrea.rasola@unipd.it\n**Dates:** 1/1/2017 to 12/31/2019\n**Tumor Focus:** plexiform neurofibromas, MPNST\n**Application**:  preclinical, translational\n&nbsp;\n**Background:** \nPlexiform neurofibroma (PN) is a complex tumor that develops within perineural sheaths of nerve bundles in neurofibromatosis type I (NF1) patients. Albeit benign, PNs can be disfiguring, can dangerously compress surrounding tissues or undergo transformation into highly aggressive sarcomas termed malignant peripheral nerve sheath tumors (MPNSTs). PN formation and growth require mutations at the NF1 gene, leading to loss of the Ras GTPase activating protein (Ras-GAP) neurofibromin and to the ensuing induction of the Ras/ERK transduction axis. Oncogenic signalling via the Ras/ERK pathway contributes to the metabolic rewiring of tumor cells, a crucial hallmark of neoplastic transformation. In tumor cells changes in mitochondrial activity lead to accumulation of oncometabolites, such as succinate, that prompt neoplastic growth via regulation of transcription factors or epigenetic changes. The role of metabolism in PN formation or in PN transformation into MPNST was never investigated. We have previously shown that in tumor cells the Ras/ERK transduction pathway has a mitochondrial branch, and that the mitochondrial chaperone TRAP1 increases intracellular succinate, thus activating the tumorigenic programs mastered by the transcription factor HIF1. These observations suggest the possibility that hyperactive ERK might target TRAP1 in mitochondria of PN cells, thus leading to succinate-dependent, pro-neoplastic HIF-1 activation. \n&nbsp;\n**Goals of Project:** \nThis project aims at investigating the possibility that hyperactive Ras/ERK signalling could contribute to pro-neoplastic metabolic rearrangements in mitochondria of neurofibroma cells by regulating TRAP1 chaperone activity, thus crucially contributing to the processes of growth and malignant transformation of PNs. We will dissect the mode of action of TRAP1, connecting it with the metabolic status of PNs and MPNSTs, which will be thoroughly investigated in in vivo tumor models.\n&nbsp;\n**Methods:**\nStarting from these premises, we will design allosteric TRAP1 inhibitors to be tested as putative anti-neoplastic compounds on PN and MPNST models. Analysis of structure-dynamics-function relationships for complexes between TRAP1 and nucleotides or small ligands will be carried out in order to achieve a computational characterization of allosteric mechanisms of regulation of TRAP1 chaperone activity, and to find out druggable sites. This information will be translated into pharmacophore models that will be first used to screen drug libraries. Analysis of the efficacy of the selected compounds as TRAP1 allosteric inhibitors will be studied by a stepwise in vitro, in cell and in vivo approach, leading to the use of first generation molecules as leads for the design and synthesis of potentially more powerful derivatives\n &nbsp;\n**Impact:**  To gain insight on the mode of action and role of TRAP1, with regards to PN and MPNST metabolism.  \n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954708\nName: ATP hydrolisis rate\nSummary:\n- Assays: ATPase activity assay\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig36B hydrolysis.xlsx, fig36C hydrolysis-subparticle.xlsx\n\n\n\n2. ID: syn64954709\nName: CRC\nSummary:\n- Assays: calcium retention capacity assay\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1\n- Data types: exel\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig37A CRC.xlsx\n\n\n\n3. ID: syn64954710\nName: NADH dehydrogenase activity\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.22_complexI.xlsx\n\n\n\n4. ID: syn64954711\nName: OCR and ECAR\nSummary:\n- Assays: oxygen consumption assay, \n- Species: Homo sapiens, Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel, excel, \n- File formats present: excel, \n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig13rowdataOCR.xlsx, fig14rowdataOCR.xlsx, Figure 44 B.xlsx, Fig.8-9_Seahorse.xls, Fig.10_Seahorse.xls\n\n\n\n5. ID: syn64954712\nName: SDH activity\nSummary:\n- Assays: sorbitol dehydrogenase activity level assay\n- Species: Mus musculus, Homo sapiens, Danio rerio\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, , Malignant Peripheral Nerve Sheath Tumor\n- Data types: csv, excel, jpg\n- File formats present: csv, , jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: SDH activity TRAP1 inhibitors.csv, cisMPNST SDH activity TRAP1 inhibitors.csv, S462 SDH activity TRAP1 inhibitors.csv, PN 95.6 SDH activity TRAP1 inhibitors.csv, cisMPNST dose-dependent SDH activity TRAP1 inhibitors.csv\n\n\n\n6. ID: syn64954713\nName: SDS and BN-PAGE\nSummary:\n- Assays: SDS-PAGE, blue native PAGE, immunoprecipitation, , gel filtration chromatography\n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , NF1\n- Data types: , word, exel, ppt\n- File formats present: , word, excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Purification recombinant human TRAP1_Batch 4.tif, Coomassie blue staining_purification human recombinant TRAP1_Batch 4.png, Fig31C BNP.docx, Fig34B IP.docx, Fig34B IP.xlsx\n\n\n\n7. ID: syn64954714\nName: Split GFP\nSummary:\n- Assays: Split GFP\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: experimentalData\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig35B split IP.xlsx, Fig35C split IP.xlsx, fig42b split.xlsx\n\n\n\n8. ID: syn64954715\nName: TRAP1-HSP90 ATPase activity\nSummary:\n- Assays: ATPase activity assay\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: csv, jpg\n- File formats present: csv, jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: TRAP1 activity drug screening.csv, Hsp90 activity TRAP1 inhibitors.csv, Dose-response curves TRAP1 inhibitors.csv, Figure TRAP1-Hsp90 activity drug screening.jpg, Figure TRAP1-Hsp90 activity Honokiol.jpg\n\n\n\n9. ID: syn64954716\nName: cell proliferation\nSummary:\n- Assays: cell proliferation assay\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1\n- Data types: csv, jpg\n- File formats present: csv, jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Cell proliferation TRAP1 inhibitors.csv, Figure Cell proliferation Compound 5.jpg, Figure Cell proliferation Compound 2.jpg, Figure Cell proliferation TRAP1 inhibitors.jpg, Figure Cell proliferation Honokiol.jpg\n\n\n\n10. ID: syn64954717\nName: cell viability\nSummary:\n- Assays: , cell viability assay\n- Species: , Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , NF1\n- Data types: , csv, image, jpg\n- File formats present: , csv, jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.11_E880 SCR NORMOXIA vs HYPOXIA 24-48-72h 14.06.2018 analisi.xls, Cell viability TRAP1 inhibitors.csv, Figure Cell viability Compound 5.tif.jpg, Figure Cell viability TRAP1 inhibitors.jpg, Figure Cell viability Honokiol.jpg\n\n\n\n11. ID: syn64954718\nName: compound list\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Structure Honokiol bis-dichloroacetate (HDCA).pdf, Structure TRAP1 inhibitors.pdf\n\n\n\n12. ID: syn64954719\nName: fluorescence microscopy\nSummary:\n- Assays: microscopy\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Image 8.czi, Image 8.tif, Image 8_stack.czi, Image 8_stack_z00.tif, Image 8_stack_z01.tif\n\n\n\n13. ID: syn64954720\nName: immunohistochemistry\nSummary:\n- Assays: immunohistochemistry, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: A green 1 left 20x.jpg, A green 1 left 40x.jpg, A green 1 right 20x.jpg, A green 1 right 40x.jpg, B red 1 left 20x.tif\n\n\n\n14. ID: syn64954721\nName: in vitro interaction\nSummary:\n- Assays: in vitro\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: word\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig33Biocore.docx\n\n\n\n15. ID: syn64954722\nName: in vitro tumorigenesis\nSummary:\n- Assays: focus forming assay, Matrigel-based tumorigenesis assay\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, Malignant Peripheral Nerve Sheath Tumor\n- Data types: csv, jpg\n- File formats present: csv, , jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: In vitro tumorigenesis TRAP1 inhibitors.csv, Dose-dependent in vitro tumorigenesis TRAP1 inhibitors.csv, Fig.26_EV - NDI1.xlsx, Figure In vitro tumorigenesis TRAP1 inhibitors.jpg, Figure dose-dependent in vitro tumorigenesis TRAP1 inhibitors.jpg\n\n\n\n16. ID: syn64954723\nName: in vivo tumorigenesis\nSummary:\n- Assays: , in vitro tumorigenesis\n- Species: , mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: , excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.7_N667-72 E880 Ad-Cre pCDH hTRAP1.xlsx, CD1 nude - sMPNST sgSCR sgTRAP1 +SIRT3 +NIC 2019.xls\n\n\n\n17. ID: syn64954724\nName: mass spec data\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel, \n- File formats present: excel, \n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig31A massData.xlsx, Fig.29_NAD+-NADH.xlsx\n\n\n\n18. ID: syn64954725\nName: mitochondrial ROS\nSummary:\n- Assays: , reactive oxygen species assay\n- Species: , Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , NF1\n- Data types: , csv\n- File formats present: , csv\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.23_ROS.xlsx, ROS levels Honokiol.csv\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn5610418","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn5610418\n\n${image?fileName=CTF Synodos Data Site Headers6%2Ejpg&align=Center&scale=100&responsive=true}\n#Welcome to Synodos NF1 Preclinical Models\nSynodos NF1 represents a unique endeavor to coordinate researchers from across scientific and clinical domains to accelerate cures for NF1.  This wiki represents an open space between the three Synodos groups.  To visit the private sites, navigate to the folder tab. \n\n\n### **Iowa, Sanford and Exemplar Genetics**\n\nData can be found [here](syn5611494). \n\n\n### **See the other team project (Minnesota, CCHMC and Recombinetics) at syn52740594**\n\n\n---\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&align=None}\n\n## Tables for Curation\n1. ID: syn63141118\nName: Synodos NF1 Patient WES Data (GSE145064)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens, \n- Individual count: 15\n- Specimen count: 46\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma, Malignant Peripheral Nerve Sheath Tumor\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: PT4-26668-A11_lane3_20180514000_S8_L003_R1_001.fastq.gz, PT4-26668-A11_lane3_20180514000_S8_L003_R2_001.fastq.gz, PT4-26668-A11_lane4_20180514000_S16_L004_R1_001.fastq.gz, PT4-26668-A11_lane4_20180514000_S16_L004_R2_001.fastq.gz, PT4-26669-A5_lane3_20180514000_S7_L003_R1_001.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn8016599","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn8016599\n\n##Modeling signaling networks of NF1-deficient Schwann cells and plexiform neurofibromas using mass spectrometry-based proteomics\n**Initiative:** Open\n&nbsp;\n**Name:** James Walker, Ph.D.\n**Contact Email:** jwalker@helix.mgh.harvard.edu \n**Dates:** 12/1/2016 to 11/30/2018\n**Tumor Focus:** plexiform neurofibromas\n**Application**: preclinical translational, mouse models \n&nbsp;\n**Background:**\nPlexiform neurofibromas (PNs) are among the most serious symptoms of NF1. Although benign, they cause signficant morbidity, and a substantial fraction transform into typically fatal malignant peripheral nerve sheath tumors. NF1 is caused by loss of neurofibromin, a protein whose best-defined function is to serve as a GTPase Activating Protein (GAP) for Ras. Consequently, loss of neurofibromin can result in misregulation of signaling downstream of Ras, the best documented being the RAF/MEK/ERK and PI3K/AKT/mTOR pathways. Although disregulated Ras signalling is believed to be the proximal cause of NF1 symptoms, it is unclear which of the numerous effectors downstream of Ras are relevant for disease progression, as are the identities of the disease-pertinent targets of the signaling pathways mediating their effects. The situation is further complicated since there is undoubtedly cross-talk between these different pathways. Despite considerable effort, no effective therapy for Ras-driven cancers has yet emerged. Furthermore, it is clear that neurofibromin has other functions that likely play a role in clinical outcomes as well. This has motivated our work to find the precise pathways that are responsible for NF1 symptoms, in the hope that this will allow better-targeted therapy. \n&nbsp; \n**Goals of Project:**\nWe aim to identify putative proteomic and/or phosphoproteomic signatures associated with loss of NF1. Recent advances in mass-spectrometry (MS)-based proteomics permit the determination of the extent, localization, and site-specific stoichiometry of protein phosphorylation. We propose using two complementary MS-based approaches to define (i) the proteome and phosphoproteome and (ii) the activated kinome signature of NF1-deficient Schwann cells (SCs). We will perform analyses on a panel of SC lines derived from PNs. Transcriptome profiling of cell lines will complement these data sets, together providing a detailed view of the cellular signaling networks and the molecular targets controlled by neurofibromin in a cell-type relevant to the disease. Finally, we will use small molecule inhibitors to both known and any novel signaling pathways we identify to examine the adaptive kinome in treated cell lines. Combining the use of a novel panel of cell lines with the sensitivity of high-end MS, we expect to identify signaling pathways and targets previously implicated as being important in NF1-associated tumors, as well as new and unexpected targets downstream of NF1. \n&nbsp;\n**Specific Aims:** \n1) Test cell lines for tumorigenic potential in vivo and optimize growth conditions of cells. For determining the proteomic and kinomic signatures associated with loss of neurofibromin, we will select NF1-deficient cell lines derived from PNs that display tumorigenic potential in vivo. Xenograft assays on PN-derived cell lines in mice will be used to evaluate their tumoigenicity in vivo.\n2) Identify phospho-targets misregulated in NF1Â¬-deficient SCs. Multiplexed quantitative mass spectrometry-based phosphoproteomics will be used to quantitatively map phosphorylation level changes across all cell lines. Novel phosphoproteins identified as being misregulated in NF1-deficient cells will be validated using western blotting using available antibodies and also in independently CRISPR-generated NF1-deficient cell lines that we have available.\t\n3) Analysis of kinome signatures of NF1-deficient SCs using Multiplexed Inhibitor Beads (MIBs) and MS analysis. Knowledge of the relative expression and activation status of the kinome of NF1-deficient cells will enable a comprehensive understanding of the signaling pathways controlled by neurofibromin and mechanisms underlying any phosphoproteome changes. Transcriptome profiling of kinases using RNAseq will enable both the global kinome signature and PTMs to be assessed relative to changes in gene expression. The main focus of our attention will be on using the MIB/MS technique to define the kinome response signature of NF1-deficient SCs to selected inhibitors that are currently in pre-clinical and clinical testing for NF1. \n4) Create a network linking altered phosphorylation events with relative level of activated kinases caused by loss of NF1. The comprehensive set of molecular data consisting of gene expression (RNAseq), global protein levels (total proteome) and protein modifications/function (phosphoproteome/kinome) for each of the cell lines (with appropriate NF1+/+ and NF1+/- controls) will enable us to focus our attention on a common signaling pathway, gene target or group of genes that have altered expression/function in NF1-deficient tumorigenic cells. By incorporating kinome data sets obtained from treating NF1Â¬-deficient SC cell lines with small molecule inhibitors we will be able to define the adaptive kinome response (â€˜reprogrammingâ€™) in NF1Â¬-deficient SCs upon drug therapies for PNs. \n&nbsp;\n**Impact:** The datasets and systems analyses described will be made publically available at SAGE/Synapse and will provide a wealth of hypotheses and opportunities for the NF1 research community to gain a better understanding of the fundamental mechanisms involved in NF1-regulated signaling and plexiform neurofibroma development. \n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954705\nName: Kinome_Data\nSummary:\n- Assays: MIB/MS\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable\n- Tumor types present: ?\n- Data types: kinomics\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Stephanie Bouley\n- Example files present: 112921_Kinome_NTAP_Walker.xlsx\n\n\n\n2. ID: syn51198962\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Stephanie Bouley\n- Example files present: C23_1_CRRA190119813-1a_HMFNJDSXX_L1_1.fq.gz, C23_1_CRRA190119813-1a_HMFNJDSXX_L1_2.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_1.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_2.fq.gz, C23_2_CRRA190119823-1a_HMG35DSXX_L4_1.fq.gz\n\n\n\n3. ID: syn64954706\nName: Proteomics_Data\nSummary:\n- Assays: TMT quantitation\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable\n- Tumor types present: ?\n- Data types: kinomics\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Stephanie Bouley\n- Example files present: 112921_Total Proteome_NTAP_Walker.xlsx, 112921_Normalized_Phosphoproteome_NTAP_Walker.xlsx\n\n\n\n4. ID: syn64954707\nName: RNAseq_Raw Data\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Not Applicable, Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Stephanie Bouley\n- Example files present: C23_1_CRRA190119813-1a_HMFNJDSXX_L1_1.fq.gz, C23_1_CRRA190119813-1a_HMFNJDSXX_L1_2.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_1.fq.gz, C23_2_CRRA190119823-1a_HMFVGDSXX_L4_2.fq.gz, C23_2_CRRA190119823-1a_HMG35DSXX_L4_1.fq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn4939910","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939910\n\n##Targeting the mechanisms underlying cutaneous neurofibroma formation in NF1: a clinical translational approach\n**Initiative:** Francis Collins\n&nbsp;\n**Name:** Matthew R. Steensma, M.D.\n**Contact Email:** Steensma@Spectrumhealth.org\n**Dates:** 7-1-15 to 5-31-17\n**Tumor Focus:** plexiform neurofibroma, MPNST\n**Application:** Imaging Biomarkers (omics data)\n&nbsp;\n**Background:** \nCutaneous neurofibromas (CNFs) are ubiquitously expressed in Neurofibromatosis Type 1 (NF1) patients. They are one of three cutaneous diagnostic criteria in addition to cafÃ©-au-lait spots and axillary freckling. They can be distinguished from other cutaneous manifestations of NF1 based on their size (0.5-3cm), sessile or polypoid morphology, and typical lack of pigment. CNFs account for substantial morbidity and disfigurement in NF1. Unlike plexiform neurofibromas, which are congenital lesions, CNFs manifest during adolescence suggesting that their pathogenesis is influenced by environmental or hormonal factors. CNFs are comprised of a confederacy of cell types with distinct embryonic lineages, including Schwann-like cells, perineural cells (neural crest or neuro-ectoderm), fibroblasts (mesoderm), and mast cells (bone marrow-derived).\n&nbsp;\nCNFâ€™s cause significant morbidity  and disfigurement in Neurofibromatosis Type 1 (NF1). They bear histologic similarity to Plexiform Neurofibromas (PNFs), however they lack malignant potential, exhibit a less aggressive growth pattern, and arise during adolescence as opposed to being congenital lesions like PNFs. These clinical observations suggest that CNF molecular pathogenesis differs from that of PNFs. To further contrast the verified differences in peripheral nerve tumors, MPNSTs are verified to be highly aggressive sarcomas that do not respond to chemotherapy.  \n&nbsp;\n**Goals of Project:** To develop new therapy strategies for peripheral nerve sheath tumors associated with Neurofibromatosis Type 1: Cutaneous Neurofibromas (CNFs) and Malignant Peripheral Nerve Sheath Tumors (MPNSTs).  \n&nbsp;\n**Specific Aims:** \n1. To demonstrate that CNFs maintain a unique, targetable genomic profile that is distinct from that of PNFs, and varies based on the stage of CNF development (incipient versus established lesions).\n2. Address a current gap in knowledge in cNF pathophysiology by performing detailed histologic and pathoanatomic analysis of clinical cNF specimens.\n3. Leverage existing models of PN tumor initiation from secondary project to generate high quality preclinical data to support PN tumor therapy trials.\n&nbsp;\n**Methods:**\nOur first research project is to determine whether targetable epigenetic alterations exist between CNFs and PNFs. We designed a surgical trial to collect highly annotated CNF tissues at various stages of disease progression. We recently completed a large epigenetic profiling study comparing harvested CNF tissues with matched, tissue-Â­â€type controls to PNFs and MPNSTs. These data are currently being analyzed. Our secondary trial objective was to define the surgical anatomy of CNFs in comparison to other types of neurofibromas that involve the dermis. \n&nbsp;\n  Our second research project addresses the hypothesis that Ras and non Ras-Â­â€dependent kinase signaling drives disease progression and therapy resistance in NF1-Â­â€related MPNSTs, and that putative MPNST genomic alterations influence cellular adaptation to tyrosine kinase inhibitor (TKI) treatment. This hypothesis is based on preliminary data where we determined the sequence of genomic alterations that occurred in a case of MPNST progression from a PNF. Various treatment timepoints are shown (below):\n${previewattachment?fileName=NTAP Summary Steensma 2%2C Figure 1%2Ejpg}\n&nbsp;\nThe earliest genomic alterations observed were MET, HGF and EGFR copy number gains. Our subsequent in vitro and in vivo modeling experiments verified the importance of RAS-Â­â€MET signal interaction not only in malignant transformation but also therapy response to MET inhibition. We employ a novel, genetically engineered NF mouse model featuring MET overexpression in myelinating peripheral nerve cells to show that the highly selective MET inhibitor, capmatinib, has exquisite activity in MET-Â­â€addicted murine MPNSTs (below).\n${previewattachment?fileName=NTAP Summary Steensma 2%2CFigure 2%2Ejpg}  \n&nbsp;\n**Impact:**  Innovative and highly translational approach to defining the pathophysiology of CNF initiation and progression, such that unique and novel preventive and/or treatment strategies for NF1 can be developed. \n&nbsp;\n**Publications:** \n* Steensma M.  Enhanced MET signaling drives malignant tumorigenesis in a mouse model of Neurofibromatosis Type 1. (submitted)\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn52299972\nName: Copy Number Variant - CNVkit\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: 0\n- Specimen count: 0\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: \n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: VA01.converted.cns, VA01.converted-scatter.png, VA02.converted.bintest.cns, VA01.converted.targetcoverage.cnn, VA02.converted-diagram.pdf\n\n\n\n2. ID: syn35562797\nName: Germline Genomic Variants - DeepVariant Pipeline (from syn31621349)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: VA01.vcf.gz, VA02.vcf.gz, VA03.vcf.gz, VA04.vcf.gz, VA05.vcf.gz\n\n\n\n3. ID: syn35562794\nName: Germline Genomic Variants - FreeBayes Pipeline (from syn31621349)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: FreeBayes_VA01.vcf.gz.tbi, FreeBayes_VA01.vcf.gz, FreeBayes_VA02.vcf.gz.tbi, FreeBayes_VA02.vcf.gz, FreeBayes_VA03.vcf.gz.tbi\n\n\n\n4. ID: syn35562795\nName: Germline Genomic Variants - Mutect2 Pipeline (from syn31621349)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: Mutect2_unfiltered_VA01.vcf.gz.tbi, Mutect2_filtered_VA01.vcf.gz, Mutect2_unfiltered_VA01.vcf.gz, Mutect2_filtered_VA01.vcf.gz.tbi, Mutect2_filtered_VA02.vcf.gz\n\n\n\n5. ID: syn35562796\nName: Germline Genomic Variants - Strelka Pipeline (from syn31621349)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: Strelka_VA01_genome.vcf.gz.tbi, Strelka_VA01_variants.vcf.gz, Strelka_VA01_variants.vcf.gz.tbi, Strelka_VA02_genome.vcf.gz.tbi, Strelka_VA02_variants.vcf.gz.tbi\n\n\n\n6. ID: syn64954683\nName: Metadata\nSummary:\n- Assays: methylation array\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: chromatinActivity\n- File formats present: txt\n- Funders: NTAP\n- Contains data created by: Benjamin Johnson\n- Example files present: STEM_synapse_metadata.txt\n\n\n\n7. ID: syn51199012\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Steven Angus\n- Example files present: 1_S1_R1_001.fastq.gz, 2_S2_R1_001.fastq.gz, 3_S3_R1_001.fastq.gz, 4b_S10_R1_001.fastq.gz, 4_S4_R1_001.fastq.gz\n\n\n\n8. ID: syn29781479\nName: NFOSIprocessing-2022-26-04\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: 0\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Matt \n- Example files present: 171105_NS500276_0097_AHH7NNBGX3_HH7NNBGX3_ATCATTCC_170065_S2_L001_R1.fastq.gz, 171105_NS500276_0097_AHH7NNBGX3_HH7NNBGX3_GCCACATA_170066_S3_L001_R1.fastq.gz, 171105_NS500276_0097_AHH7NNBGX3_HH7NNBGX3_ACCACTGT_170067_S1_L001_R1.fastq.gz, 171028_NS500270_0211_AHH7KLBGX3_HH7KLBGX3_CTGGCATA_169795_S2_L001_R1.fastq.gz, 171028_NS500270_0211_AHH7KLBGX3_HH7KLBGX3_ACCTCCAA_169794_S1_L001_R1.fastq.gz\n\n\n\n9. ID: syn64954684\nName: Processed_beta_matrix\nSummary:\n- Assays: methylation array\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: chromatinActivity\n- File formats present: txt\n- Funders: NTAP\n- Contains data created by: Benjamin Johnson, Sara Gosline\n- Example files present: STEM_NTAP_CNF_PNF_processed_beta_matrix.txt.gz, STEM_NTAP_CNF_PNF_processed_beta_matrix.txt\n\n\n\n10. ID: syn64954685\nName: Raw_CNF_PNF_EPIC_idats\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 38\n- Specimen count: 60\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: chromatinActivity\n- File formats present: idat\n- Funders: NTAP\n- Contains data created by: Benjamin Johnson\n- Example files present: 201233650066_R08C01_Grn.idat, 201233650066_R08C01_Red.idat, 201233650020_R05C01_Grn.idat, 201233650020_R05C01_Red.idat, 201233650020_R06C01_Grn.idat\n\n\n\n11. ID: syn64954686\nName: Van Andel - RNAseq and WXS\nSummary:\n- Assays: RNA-seq, whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: 11\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Plexiform Neurofibroma\n- Data types: geneExpression, genomicVariants\n- File formats present: excel, fastq\n- Funders: NTAP\n- Contains data created by: Steven Angus, Matt \n- Example files present: DNA RNA Seq Analysis Manifest Form_UNC TC Facility_v1.xlsx, 1_S1_R1_001.fastq.gz, 2_S2_R1_001.fastq.gz, 3_S3_R1_001.fastq.gz, 4b_S10_R1_001.fastq.gz\n\n\n\n12. ID: syn64954687\nName: Whole Exome Sequencing of Mouse Samples\nSummary:\n- Assays: whole exome sequencing\n- Species: Mus musculus\n- Individual count: 2\n- Specimen count: 7\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Megan Bowman\n- Example files present: NF1-P53T_R1.fastq.gz, NF1-P53T_R2.fastq.gz, NF1-METblood_R1.fastq.gz, NF1-METblood_R2.fastq.gz, NF1-METtcells_R1.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn11374353","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374353\n\n###Identification of pathways triggered by Schwann cell-fibroblast interactions driving cutaneous neurofibroma growth\n\n&nbsp;\n\n#####**PI:**  Eduard Serra\n\n&nbsp;\n\n######**Background and Study Design:**  \n\nCutaneous neurofibromas (cNF) are benign tumors of the peripheral nerves present in almost all neurofibromatosis Type 1 (NF1) patients. cNFs are composed of different cell types, mainly Schwann cells (SCs) and fibroblasts (FBs). Inactivation of the NF1 gene in SCs is believed to be the cause triggering cNF formation. Extensive analysis has shown that from a genetic and genomic perspective, there is no additional recurrent genetic alteration besides the NF1 inactivation involved in cNFs. Despite its simple genetic etiology, the contribution of the interactions among cells composing cNFs need to be investigated to better understand their role in cNF formation and their potential influence on treatment response. In this work, we propose to use co-cultures of cNF-derived primary SCs and FBs to identify expression signatures in cNFs that are specifically due to SC-FB heterotypic interactions. For this purpose we will compare RNA-Seq data from cNFs, their single cell primary cultures and co-cultures of SCs and FBs. Furthermore, we will identify the genetic variation present in gene coding regions of neurofibroma donors. Since SCs and FBs used in co-cultures will belong to different individuals, we estimate to dissect about 75% of the expression signature due to SC-FB interactions by assigning each differently expressed gene to a specific cell type, according to their genetic variation. Signaling pathways represented by expression signatures will be analyzed and their disruption tested functionally.\n\n&nbsp;\n\n######**Deliverables:**\n\nObtain an expression signature of cNFs specifically due to SC-FB interactions. Dissect from this signature which genes are expressed in SCs and which in FBs. Identify from signatures SC-FB specific signaling pathways. Test the functional impact of their disruption.\n\n&nbsp;\n\n######**Expected Outcomes:**\n\nUnderstand the signaling between SCs and FBs within cNFs and their importance and impact on their viability, proliferation capacity and contribution to cNF development.\n\n&nbsp;\n\n######**Challenges and Gaps:**\n\ncNFs are not only composed by SCs and FBs. Probably interaction with mast cells and other cell types play their role in cNF formation. The present work is only focused in the interaction of the two main cell types present in cNFs.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954755\nName: 12 month deliverables\nSummary:\n- Assays: , whole exome sequencing\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 10\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: , genomicVariants\n- File formats present: pdf, fastq\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: coculture_protocol.pdf, 1CNF_FB_1.fastq.gz, 1CNF_FB_2.fastq.gz, 1CNF_SC_1.fastq.gz, 1CNF_SC_2.fastq.gz\n\n\n\n2. ID: syn64954756\nName: 18 month deliverables\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 13\n- Specimen count: 28\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Christina Parry\n- Example files present: 1cNF_1.fastq.gz, 1cNF_Fibroblasts_1.fastq.gz, 1cNF_2.fastq.gz, 1cNF_Fibroblasts_2.fastq.gz, 1cNF_Fibroblasts_1cNF_SchwannCells_2.fastq.gz\n\n\n\n3. ID: syn64954757\nName: 24 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: 17CNF1_FB_17CNF1_SC_coculture.csv, 17CNF1_FB_1CNF_SC_coculture.csv, 17CNF1_FB_27CNF1_SC_coculture.csv, 17CNF1_FB_28CNF1_SC_coculture.csv, 1CNF_FB_17CNF1_SC_coculture.csv\n\n\n\n4. ID: syn64954758\nName: 36 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Helena  Mazuelas\n- Example files present: Luminex_raw_data.xlsx, Experimental_Description.pdf, ClickiT-EdU_27cNF_coculture.pdf, ClickiT-EdU_27cNF_SC_culture.pdf, ClickiT-EdU_28cNF_coculture.pdf\n\n\n\n5. ID: syn64954759\nName: 6 month deliverables\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: cNF_ESerra_mutations_analysis.xlsx\n\n\n\n6. ID: syn51930741\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 13\n- Specimen count: 28\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: quant.sf, quant.genes.sf, quant.sf, quant.sf, quant.genes.sf\n\n\n\n7. ID: syn64954760\nName: NF-OSI-processed-data\nSummary:\n- Assays: , RNA-seq\n- Species: , Homo sapiens\n- Individual count: 13\n- Specimen count: 28\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: , geneExpression, AlignedReads\n- File formats present: , sf, bam\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: 17cNF_Fibroblasts_27cNF_SchwannCells_1_fastqc.html, 1cNF_Fibroblasts_17cNF_SchwannCells_2_fastqc.html, 17cNF_Fibroblasts_17cNF_SchwannCells_1_fastqc.html, 17cNF_Fibroblasts_17cNF_SchwannCells_2_fastqc.zip, 1cNF_1_fastqc.html\n\n\n\n8. ID: syn51198956\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: ?\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: 28\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Bernat Gel Moreno\n- Example files present: 1cNF_1.fastq.gz, 1cNF_Fibroblasts_1.fastq.gz, 1cNF_2.fastq.gz, 1cNF_Fibroblasts_2.fastq.gz, 1cNF_Fibroblasts_1cNF_SchwannCells_2.fastq.gz\n\n\n\n9. ID: syn51199729\nName: NFOSI-WES-To-Process-2024-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Bernat Gel Moreno\n- Example files present: 1CNF_FB_1.fastq.gz, 1CNF_FB_2.fastq.gz, 1CNF_SC_1.fastq.gz, 1CNF_SC_2.fastq.gz, 17CNF1_FB_1.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn21650484","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21650484\n\n\n##Stem cell derived RGCs: Improving the success of transplantation strategies\n\n##VRI Subgroup: \nExogenous RGC Replacement\n\n##Principal Investigators: \nMichael Young, PhD (Massachusetts Eye and Ear Infirmary)\nPetr Baranov, MD, PhD (Massachusetts Eye and Ear Infirmary)\n\n##Personnel:\nPetr Baranov, MD, PhD (PI)\n\n##Lay Abstract\n\nOur overall goal is to improve the success of RGC transplantation, using mouse cells, together with tissue engineering and pig to pig transplantation studies.  We will first identify and optimize key variables using mouse cells that can be applied for pig, non-human primate and human retinal ganglion cell precursors. The premise is that the development of RGCs from stem cells is conserved and the cues we identify may be relevant for all RGCs.  Testing them in mouse has two key advantages:  The timeframe for differentiation is much shorter, which allows one to test more variables; and the mouse model allows for mouse to mouse (allograft) studies which is a likely therapeutic strategy in humans. We have shown that mouse stem cells-derived RGCs are diverse, functional and integrate into healthy and RGC-depleted retinas following injection into the chamber of the eye in front of the retina. We have also demonstrated long-term survival and growth of processes into the optic nerve.   We have three sub-aims for this approach:  1 ) Identifying the stage of differentiation with the highest potential for transplantation 2. Evaluate different types of RGCs for transplantation studies 3.  Improving RGC maturation in retinal tissue, differentiated from stem cells. We will work closely with team members to develop appropriate differentiation (DZ) and transplantation (JG) protocols. \nWe will also develop novel tissue engineered transplants aimed at improving graft success.  Using cells and protocols from Aim 1, we will develop polymer composite grafts capable of improving survival, engraftment, and differentiation of transplanted RGCs.  Cells from JG and DZ, along with cells from Aim 1 will be used for these studies.   Lastly, building upon studies by team members using mouse and human RGCs, we will develop pig RGCs for the purpose of performing pig-pig allograft (same species) studies in disease models.  Human and mouse protocols from DZ and PB will be used to generate pig RGCs.\n\n\n## Tables for Curation\n1. ID: syn64954825\nName: Bulk RNA Sequencing Donor RGCs\nSummary:\n- Assays: targeted exome sequencing, \n- Species: Mus musculus, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Not Applicable, \n- Tumor types present: Not Applicable, \n- Data types: AlignedReads, \n- File formats present: excel, \n- Funders: GFF\n- Contains data created by: Julia Oswald, Christina Parry\n- Example files present: TMM_normed_counted_exons_27_04_20_full.xlsx, TMM_normed_counts_full.xlsx, synapse_storage_manifest_rnaseqtemplate.csv\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn7231973","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn7231973\n\n##Perpetuating NF1+/- and NF1-/- plexiform neurofibroma-derived tumor cells  through the generation of induced pluripotent stem (iPS) cells\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** Eduard Serra, Ph.D.\n**Contact Email:** eserra@igtp.cat\n**Dates:** 5-1-13 to 8-31-15\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Preclinical Translational models\n&nbsp;\n**Background:** Neurofibromatosis type 1 (NF1) associated neurofibromas are benign tumors of the peripheral nerves that are difficult to study due to their heterogeneous cellular composition and their genetic heterogeneity regarding the NF1 mutational status of the different cell types. Plexiform neurofibromas (pNFs) differ from discrete neurofibromas (dNFs) in their moment of appearance (though to be congenital in pNFs), the importance of the extension of the nerve and tissues affected (larger in pNFs) and their potential to progress to malignancy, not present in dNFs. Regarding genomics and transcriptomics, Schwann cells (SC) derived from dNFs and pNFs are very much alike. So what is different among these tumors that confer pNFs a risk to become malignant? The extent of affected tissue? The location? The temporal window at which a neural crest-derived cell committed to the SC lineage acquires a double inactivation of the NF1 gene? A particular cellular composition? A combination of factors?\n&nbsp;\n**Goals and Specific Aims:**\n*  Explore the degree of genomic, molecular and cellular variation within a whole plexiform neurofibroma (pNF).\n*  Obtain, authenticate and characterize NF1-/- and NF1+/- induced pluripotent stem cells (iPSC) derived from pNFs.\n&nbsp;\n**Publications:** a manuscript describing this work is currently in progress.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n3- Download the data [here](syn17018746)\n\n## Tables for Curation\n1. ID: syn64954703\nName: Exome\nSummary:\n- Assays: , whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 9\n- Specimen count: 35\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: , genomicVariants\n- File formats present: bai, fastq\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: PNF3AF.postprocessed.bai, PNF3AF_1.fastq.gz, PNF3AF_2.fastq.gz, 3PNF_S_1.fastq.gz, 3PNF_SiPSsv_MM_1.fastq.gz\n\n\n\n2. ID: syn51200209\nName: NFOSI-WES-To-Process-2023-15-03\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Bernat Gel Moreno\n- Example files present: PNF3AF.postprocessed.bai, PNF3AF_1.fastq.gz, PNF3AF_2.fastq.gz, 3PNF_S_1.fastq.gz, 3PNF_SiPSsv_MM_1.fastq.gz\n\n\n\n3. ID: syn64954704\nName: SNParray\nSummary:\n- Assays: SNP array\n- Species: Homo sapiens\n- Individual count: 23\n- Specimen count: 40\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: PNF1A.txt, PNF1B.txt, PNF1C.txt, PNF1D.txt, PNF3Y.txt\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn23651229","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn23651229\n\n# Ultra-low-pass whole genome sequencing of plasma cfDNA from patients with plexiform neurofibroma and malignant peripheral nerve sheath tumors. \n\n#### **Principal Investigators:** Jack Shern, MD,  Angela Hirbe, MD/PhD and Aadel Chaudhuri, MD/PhD\n#### **Project Lead / Data Coordinator:** R. Taylor Sundby, MD and Jeff Szymanski, MD/PhD\n#### **Institution:** National Cancer Institute - Pediatric Oncology Branch and Washington University in St Louis\n\n#### **Project Description**\nThe leading cause of mortality for patients with the neurofibromatosis type 1 (NF1) cancer predisposition syndrome is the development of malignant peripheral nerve sheath tumor (MPNST), an aggressive soft tissue sarcoma. In the setting of NF1, this cancer type frequently\narises from within its common and benign precursor, plexiform neurofibroma (PN). Transformation from PN to MPNST is challenging to diagnose due to difficulties in distinguishing cross-sectional imaging results and intralesional heterogeneity resulting in biopsy sampling errors. This multi-institutional study from the National Cancer Institute and Washington University in St. Louis used fragment size analysis and ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) to distinguish between MPNST and PN in patients with NF1. Results and analysis are published  in \"Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study\" (https://doi.org/10.1371/journal.pmed.1003734). \n\n## Tables for Curation\n1. ID: syn52299273\nName: Copy Number Variant - CNVkit\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: Plexiform Neurofibroma, Not Applicable, Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: ?\n- Funders: NIH-NCI, Childrenâ€™s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: cnvkit.reference.target-tmp.bed, cnvkit.reference.antitarget-tmp.bed, lib003.converted.cnr, lib003.converted.bintest.cns, lib009.converted-scatter.png\n\n\n\n2. ID: syn35562839\nName: Germline Genomic Variants - DeepVariant Pipeline (from syn31726450)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: vcf\n- Funders: NIH-NCI, Childrenâ€™s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: lib003.vcf.gz, lib009.vcf.gz, lib012.vcf.gz, lib014.vcf.gz, lib019.vcf.gz\n\n\n\n3. ID: syn35562836\nName: Germline Genomic Variants - FreeBayes Pipeline (from syn31726450)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: , Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NIH-NCI, Childrenâ€™s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: FreeBayes_lib003.vcf.gz.tbi, FreeBayes_lib009.vcf.gz.tbi, FreeBayes_lib012.vcf.gz, FreeBayes_lib009.vcf.gz, FreeBayes_lib019.vcf.gz.tbi\n\n\n\n4. ID: syn35562837\nName: Germline Genomic Variants - Mutect2 Pipeline (from syn31726450)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 42\n- Specimen count: 90\n- Diagnoses present: , Neurofibromatosis type 1, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NIH-NCI, Childrenâ€™s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: Mutect2_unfiltered_lib003.vcf.gz.tbi, Mutect2_filtered_lib003.vcf.gz, Mutect2_filtered_lib009.vcf.gz, Mutect2_filtered_lib012.vcf.gz.tbi, Mutect2_filtered_lib009.vcf.gz.tbi\n\n\n\n5. ID: syn35562838\nName: Germline Genomic Variants - Strelka Pipeline (from syn31726450)\nSummary:\n- Assays: , whole genome sequencing\n- Species: , Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: , Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: ?\n- Data types: \n- File formats present: , vcf\n- Funders: NIH-NCI, Childrenâ€™s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by: NF Service\n- Example files present: Strelka_lib003_genome.vcf.gz.tbi, Strelka_lib003_variants.vcf.gz.tbi, Strelka_lib012_variants.vcf.gz.tbi, Strelka_lib003_variants.vcf.gz, Strelka_lib009_variants.vcf.gz\n\n\n\n6. ID: syn29784079\nName: NFOSIprocessing-2022-26-04\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown\n- Tumor types present: Plexiform Neurofibroma, Not Applicable, Malignant Peripheral Nerve Sheath Tumor\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by:  \n- Example files present: lib014.dedup.sorted.bam, lib003.dedup.sorted.bam, lib012.dedup.sorted.bam, lib009.dedup.sorted.bam, lib023.dedup.sorted.bam\n\n\n\n7. ID: syn64954906\nName: ULP Whole Genome Sequencing\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 59\n- Specimen count: 117\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, Unknown, \n- Tumor types present: Plexiform Neurofibroma, Not Applicable, Malignant Peripheral Nerve Sheath Tumor, \n- Data types: genomicVariants, clinical, metadata\n- File formats present: bam, excel, \n- Funders: NIH-NCI, Childrenâ€™s Cancer Foundation, Cancer Research Foundation, The V Foundation for Cancer Research, Center for Cancer Research\n- Contains data created by:  \n- Example files present: lib014.dedup.sorted.bam, lib003.dedup.sorted.bam, lib012.dedup.sorted.bam, lib009.dedup.sorted.bam, lib023.dedup.sorted.bam\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn52740594","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn52740594\n\n${image?fileName=CTF Synodos Data Site Headers6%2Ejpg&align=None&scale=100&responsive=true&altText=}\n\n#Welcome to Synodos NF1 Preclinical Models\nSynodos NF1 represents a unique endeavor to coordinate researchers from across scientific and clinical domains to accelerate cures for NF1.  This wiki represents an open space between the three Synodos groups.  To visit the private sites, navigate to the folder tab. \n\n\n### **Minnesota, CCHMC and Recombinetics**\n\nThe data for this team can be found [here](https://www.synapse.org/#!Synapse:syn5611496). \n\n### **See the other team project (Iowa, Sanford and Exemplar Genetics) at syn5610418**\n\n\n---\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&align=None}\n\n## Tables for Curation\n1. ID: syn65468086\nName: Minnesota CCHMC Recombinetics Team Data\nSummary:\n- Assays: conventional MRI, RNA-seq, cell viability assay, \n- Species: , Sus scrofa, Homo sapiens\n- Individual count: 20\n- Specimen count: 21\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: , Plexiform Neurofibroma, Malignant Peripheral Nerve Sheath Tumor\n- Data types: image, geneExpression, drugScreen, \n- File formats present: excel, 7z, fastq, txt, doc, zip, pzfx, csv, R script, hdf5, sf, \n- Funders: CTF\n- Contains data created by: Sue Rathe, Jon Hawkinson, Kyle Williams, Mike Mason, Robert Allaway, Nasim Sanati, Sara Gosline,  \n- Example files present: Description of Pig Imaging Files.xlsx, Pig1728_DICOM.7z, Pig1734_DICOM.7z, HSC1L_S27_R1_001.fastq.gz, HSC1L_S27_R2_001.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn18904024","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn18904024\n\nPROJECT TITLE: Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.\n\nAUTHORS: J. Elliott Robinson^1^, Gerard M. Coughlin^1^, Acacia M. Hori^1^, Elisha D. Mackey^1^, Jounhong Ryan Cho^1^, Zeynep Turan^1^, Tommaso Patriarchi^2^, Lin Tian^2^, and Viviana Gradinaru*^1^\n\nAFFILIATIONS:\n^1^Division of Biology and Biological Engineering, California Institute of Technology, 1200 E California Blvd, Pasadena, CA 91125, USA\n^2^Department of Biochemistry and Molecular Medicine, University of California, Davis, One Shield Ave, Davis, CA 95616, USA\n\nABSTRACT: \n\nNeurofibromatosis type 1 (NF1) is an autosomal dominant disorder whose neurodevelopmental symptoms include impaired executive function, attention, and spatial learning that could be due to perturbed mesolimbic dopaminergic circuitry. However, these circuits have never been directly assayed in vivo. We employed the genetically encoded optical dopamine sensor dLight1 to monitor dopaminergic neurotransmission in the ventral striatum of NF1 mice during motivated behavior. Additionally, we developed novel systemic AAV vectors to facilitate morphological reconstruction of dopaminergic populations in cleared tissue. We found that NF1 mice exhibit -reduced spontaneous dopaminergic neurotransmission that was associated with excitation/inhibition imbalance in the ventral tegmental area and abnormal neuronal morphology. NF1 mice also had more robust dopaminergic and behavioral responses to salient visual stimuli, which were stimulus-dependent, independent of learning, and rescued by optogenetic inhibition of GABAergic neurons in the VTA. Overall, these studies provide a first in vivo characterization of dopaminergic circuit function in the context of NF1 and reveal novel pathophysiological mechanisms. \n\nFUNDING: National Institutes of Health, Heritage Medical Research Institute, the Tianqiao and Chrissy Chen Institute for Neuroscience, the National Science Foundation, the Children's Tumor Foundation, and the National Science and Engineering Research Council of Canada \n\n## Tables for Curation\n1. ID: syn65468113\nName: Optical Dopamine Monitoring with dLight1 in NF1 Model Mice\nSummary:\n- Assays: , contextual conditioning behavior assay, in vivo bioluminescence, whole-cell patch clamp, immunofluorescence, HPLC-ED, active avoidance learning behavior assay , novelty response behavior assay\n- Species: , Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: , behavior process, electrophysiology, immunoassay, proteomics\n- File formats present: excel, pdf\n- Funders: CTF\n- Contains data created by: Elliott Robinson\n- Example files present: Supplementary_Statistical_Analysis.xlsx, Cued_Fear_Conditioning.xlsx, dLight_Light_and_Tone_Response.xlsx, Electrophysiology.xlsx, Histological_Morphological_Analysis.xlsx\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn22267284","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22267284\n\n## **Mapping and Identifying the Roles of Protein Glycosylation in Neurofibromatosis 1**\n\n### CTF Young Investigator:\n#### Kevin Bruemmer\n\n### Investigator Institution:\nStanford University\n\n### Abstract:\nNeurofibromin is a regulator of cancer driver proteins through its functional role as a Ras-GTPase activating protein. Upon loss-of-function mutations to neurofibromin, patients develop benign or malignant nerve sheath tumors that lead to the disease neurofibromatosis 1 (NF1), affecting 1 in 2,000 people. Due to the complex signaling network of neurofibromin and the cancer-driver pathways it regulates, phosphorylation post-translation modifications have been extensively studied to explain the biological mechanisms for tumor development. Protein glycosylation, specifically N-acetylglucosamine (GlcNAc), is known to have significant crosstalk with phosphorylation sites in the proteome, but has never been studied in the context of a living model system for potential regulation and contribution to the pathogenesis of NF1. To better characterize glycosylation changes at various stages of NF1 malignancies, this proposal aims to develop three complimentary chemical biology approaches to create tools for the understanding of protein GlcNAcylation in cellular model systems of NF1 and MPNSTs. We will use glycoproteomics to investigate how loss of neurofibromin affects O-GlcNAc incorporation in the proteome to reveal key sites of biological regulation affected by the Ras cancer driver pathway. We will also perform protein engineering on a N-acetylglucosamine transferase V (GnT-V), known to be overexpressed in malignant tumors, to identify protein substrates in non-malignant and malignant Schwann cells. Revealing the substrate scope of GnT-V will allow the identification of biological pathways that are aberrant in malignant nerve cells due to increased glycosylation at specific glycosites. We will also biochemically investigate glycosylation marks directly on neurofibromin, to give a clearer picture of how post-translational modifications affect the interaction of neurofibromin with cancer driver proteins and affect neurofibromin localization.\n\n## Tables for Curation\n1. ID: syn64954865\nName: 20201125-ipNF0.23 and ipnF05.5 O-glycosylation\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Not Applicable, \n- Data types: proteomics, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Kevin Bruemmer, Anh Nguyet Vu\n- Example files present: 023_cell_O_Glycan.xlsx, 055_cell_O_Glycan.xlsx, synapse_storage_manifest_proteomicsassaytemplate.csv\n\n\n\n2. ID: syn64954866\nName: NF1 Proteomics\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Not Applicable, \n- Data types: proteomics, \n- File formats present: raw, \n- Funders: CTF\n- Contains data created by: Kevin Bruemmer, Anh Nguyet Vu\n- Example files present: 202103_09_NF1_023_2Az.raw, 202103_09_NF1_023_6Az.raw, 202103_09_NF1_023_DMSO.raw, 202103_09_NF1_023_GalNAz.raw, 202103_09_NF1_023_GalNAzMCR.raw\n\n\n\n3. ID: syn64954867\nName: Neurofibromin Immunoprecipitation 20201123\nSummary:\n- Assays: mass spectrometry, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: Not Applicable, \n- Tumor types present: Unknown, \n- Data types: proteomics, \n- File formats present: txt, \n- Funders: CTF\n- Contains data created by: Kevin Bruemmer, Anh Nguyet Vu\n- Example files present: NF_IP_proteinGroups_20201123.txt, allPeptides.txt, evidence.txt, syn23573389_synapse_storage_manifest.csv\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn4939878","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939878\n\n##Development of a Child Neurofibromatosis Type 1 Health Related Quality of Life Measure\n**Initiative:** Patient Reported Outcome (PRO) \n&nbsp;\n**Name:** Nancy Swigonski, MD, MPH (Principal Investigator)\n**Name:** Kavitha Nutakki, MBBS, MPH (Project Manager)\n**Contact Email:** knutakki@iupui.edu\n**Dates:** 2-1-14 to 1-31-17\n**Tumor Focus:** plexiform neurofibroma\n**Disease Focus:** Neurofibromatosis Type 1 (NF1)\n**Application**: Clinical Endpoint Tool\n&nbsp;\n**Goals of Project:** To develop and test the feasibility, reliability and validity of the child self-report and parent proxy-report versions of the Pediatric Quality of Life InventoryTM (PedsQLTM) NF1 module.\n&nbsp;\n**Aims:** To develop and test the measurement properties of the Pediatric Quality of Life InventoryTM (PedsQLTM) Neurofibromatosis Type 1 Module for pediatric patients ages 5-25 with NF1 from the perspectives of patients and parents.\n&nbsp;\n**Impact**: The PedsQLTM NF1 Module Scales demonstrated acceptable to excellent measurement properties, and may be utilized as standardized metrics to assess NF1-specific symptoms and problems in clinical research and practice in children, adolescents, and young adults. The PedsQLâ„¢ NF1 Module will have a significant impact on the design of clinical trials targeted to better understand and improve clinical treatment for NF1. \n&nbsp;\n**Publications**:  \n1.\tNutakki K, Varni JW, Steinbrenner S, Draucker CB, Swigonski NL. Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods. J Neurooncol. 2017 Mar;132(1):135-143. doi: 10.1007/s11060-016-2351-2. Epub 2017 Jan 11. PubMed PMID: 28078640, http://link.springer.com/article/10.1007%2Fs11060-016-2351-2 \n&nbsp;\n2.\tDraucker CB, Nutakki K, Varni JW, Swigonski NL. The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives. J Spec Pediatr Nurs. 2017 Feb 15. doi: 10.1111/jspn.12174. [Epub ahead of print] PubMed PMID: 28198162, http://onlinelibrary.wiley.com/doi/10.1111/jspn.12174/abstract\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954678\nName: PRO Reports\nSummary:\n- Assays: questionnaire\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: surveyData\n- File formats present: csv\n- Funders: NTAP\n- Contains data created by: Sara Gosline\n- Example files present: NF study data_IUSM 5.16.2017_responses.csv, NF study data_IUSM 5.16.2017_variables.csv\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn11681835","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11681835\n\n###Novel Therapeutics in Malignant Peripheral Nerve Sheath Tumor (MPNST)\n\n&nbsp;\n\n#####**PI:**  Ping Chi, MD, PhD\n**Memorial Sloan Kettering Cancer Center **\n\n&nbsp;\n\n######**Background:**  \n\nMalignant Peripheral Nerve Sheath Tumor (MPNST) arising from the cellular component of the peripheral nerves represents a group of highly aggressive soft tissue sarcomas with limited treatment options. They can occur in the setting of type I neurofibromatosis (NF1-associated), or sporadically or in association with prior radiotherapy (RT-associated). Using comprehensive genomic approaches, we and others have discovered that the majority of MPNSTs have inactivation of three tumor suppressor pathways, including the NF1, the CDKN2A (INK4A/ARF) and the Polycomb repressive complex 2 (PRC2) pathways. Here, we propose to use multidisciplinary approaches to establish authentic MPNST model systems for preclinical investigation. We will also evaluate a combination treatment strategy of trametinib (a MEK inhibitor) and ribociclib (a CDK4/6 inhibitor) in various cell line and animal models of MPNST. Lastly, we will conduct a screen using RNA interference technology to identify and characterize the genes that are important for MPNST growth and survival when the PRC2 pathway is inactivated. These studies will build important resources for the NF1-research community and can identify novel treatment strategies and streamline clinical therapeutic development for patients with NF1-associated MPNSTs. \n\n&nbsp;\n\n######**Technical Study Design:**  \n\nMPNST arising from peripheral nerves represents a group of highly aggressive soft tissue sarcomas with limited treatment options. Using comprehensive genomic approaches, we and others recently discovered concurrent inactivating mutations of the Polycomb repressive complex 2 (PRC2) core components (EED or SUZ12), CDKN2A, and NF1. The highly recurrent and specific inactivation of PRC2, NF1 and CDKN2A, posits their critical and potentially cooperative roles in MPNST pathogenesis. MPNSTs with PRC2 loss showed complete loss of H3K27me3 and aberrant transcriptional activation of multiple PRC2-repressed homeobox master regulators and their regulated developmental pathways. Interestingly, Both PRC2-loss and PRC2-wild type MPNSTs and plexiform neurofibromas express high levels of ETV1 and are dependent on ETV1 for cell growth and survival and tumorigenesis. ETV1 and NF1 loss cooperates in MPNST oncogenesis. Here, we propose to build authentic in vitro and in vivo PDX and GEM MPNST modes, evaluate the combination strategy of MEK and CDK4/6 inhibitors to target NF1 loss-ETV1 cooperation and CDKN2A loss in preclinical models, and   investigate the therapeutic vulnerability of PRC2 loss using a non-biased RNAi based screen and subsequent validation. This proposal employs multidisciplinary integrative approaches and leverages the expertise of team of mentors and the sarcoma DMT. These studies will establish important resources for NF1-research, and provide of novel combination strategies in targeting transcriptional dysregulation with near-term translation potential in MPNST therapeutics. They will also provide mechanistic and therapeutic insights of PRC2 loss involved in MPNST tumorigenesis, which may apply to other cancer types with PRC2 functional loss.\n\n&nbsp;\n\n######**Hypothesis and Deliverables:**\n\nMPNSTs represent a group of highly aggressive soft tissue sarcomas that may occur in distinct clinical settings: NF1-associated, sporadic or radiotherapy (RT)-associated. Using comprehensive and integrative genomic approaches, we have identified recurrent loss of function genetic alterations of three central pathways: Polycomb repressive complex 2 (PRC2, 80%) core components (EED or SUZ12), CDKN2A (81%) and NF1 (>70% of non-NF1-associated) in all MPNSTs, and the three components significantly co-occur1-3. **_These data suggest_** that, despite the clinical and histological heterogeneity, the NF1-associated, sporadic and RT-associated MPNSTs represent a relatively homogeneous group of disease at the molecular level. We demonstrated that MPNSTs with complete PRC2 loss showed complete loss of H3K27me3 and aberrant transcriptional activation of multiple PRC2-repressed homeobox master regulators and their regulated developmental pathways. Introduction of the PRC2 component in a PRC2-deficient MPNST cell line restored H3K27me3 and decreased cell growth. The highly recurrent and specific inactivation of PRC2, NF1 and CDKN2A posits their critical and potentially cooperative roles in MPNST pathogenesis3. Using H3K27me3 IHC based clinical assay, we and others have confirmed loss of H3K27me3 staining indicative of PRC2 loss in ~ 60-70% of high grade NF1-associated MPNSTs4,5. Moreover, H3K27me3 IHC staining is universally intact in neurofibromas including plexiform neurofibromas, but >60% NF1-associated MPNSTs have lost H3K27m3 IHC staining, suggesting that the PRC2 loss is a critical and recurrent event in malignant transformation from benign neurofibroma to MPNST, which likely dictate the clinical behavior and therapeutic responses.  \n\n&nbsp;\n\n**_Based on these observations, we hypothesize_** that the frequent and concurrent CDKN2A loss and NF1 loss, as well as PRC2 loss in NF1-associated MPNSTs may create therapeutic opportunities for novel therapeutics development and H3K27me3 IHC may represent a novel therapeutic biomarker in MPNST that specifically target PRC2 loss. \n\n&nbsp;\n\nHere, **_we propose_** a focused investigation of specific aims centered on creating authentic model systems for novel therapeutic development to target the recurrent genetic alterations encompassing NF1, CDKN2A and PRC2 loss in NF1-associated MPNST. Given the molecular homogeneity, **_these studies will also provide_** us with the molecular underpinnings of therapeutic vulnerabilities of PRC2 loss in all MPNSTs, and shall facilitate therapeutic development for this difficult disease and other tumors that are dependent on PRC2 functional loss.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n## Tables for Curation\n1. ID: syn64954766\nName: NF-OSI-processed-data\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: NF Service\n- Example files present: SRR19761312_2_fastqc.zip, SRR19761310_1_fastqc.zip, SRR19761311_1_fastqc.html, SRR19761310_1_fastqc.html, SRR19761311_1_fastqc.zip\n\n\n\n2. ID: syn51199007\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: RNA-seq, single-cell RNA-seq\n- Species: Homo sapiens\n- Individual count: 41\n- Specimen count: 41\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: ?\n- Contains data created by: Christina Parry\n- Example files present: SRR19761314_1.fastq.gz, SRR19761315_1.fastq.gz, SRR19761320_1.fastq.gz, SRR19761321_1.fastq.gz, SRR19761327_1.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn26238842","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn26238842\n\n# Signaling pathways regulated by nitrated proteins as novel therapeutic targets for neurofibromatosis type 2\n## CTF Young Investigator Award\n\n### Principal Investigator: Maria C. Franco\n### Project Lead / Data Coordinator: Maria C. Franco,  Isabelle E. Logan\n### Institution: Oregon State University, University of Central Florida\n\n### Project Description:\nNeurofibromatosis type 2 (NF2) is a genetic disorder caused by inactivating mutations in the gene encoding the tumor suppressor merlin. NF2 patients develop schwannomas, meningiomas, and ependymomas throughout their life. NF2 patients have few therapeutic options; given the chronic and recurring nature of NF2, careful monitoring and resection radio surgery remains the treatment of choice. Further understanding the drivers of cell proliferation in NF2 and identifying new potential therapeutic targets remains paramount to improve the selectivity of drugs intended for the treatment of these chronic, recurrent tumors. Our group made a fundamental discovery: production of the powerful oxidant peroxynitrite and subsequent tyrosine (Tyr) nitration, an oxidative modification to proteins that occurs in pathological conditions, are essential for NF2 schwannoma cell survival. Excitingly, protein Tyr nitration is very low or absent in healthy cells. Our published and preliminary data posit nitrated proteins as a new category of tumor-directed targets for the development of tumor-directed therapies. We are determined to identify the role of nitrated proteins in the pathogenesis of NF2 and propose Tyr nitrated proteins are a novel therapeutic target. We have identified a number of proteins that are endogenously nitrated in vestibular schwannomas (VS) from NF2 patients. Six of these nitrated proteins are directly involved in signaling pathways dysregulated by the loss of merlin: Galectin 1 (Gal-1), Ras homolog family member A (RhoA), RhoC, Ras related protein 35, 14-3-3, Vimentin and Heat shock protein 90 (Hsp90). We discovered that nitrated Hsp90 supports schwannoma cell survival through a gain-of-function, but we also discovered that Hsp90 is not the only nitrated protein with pro-tumorigenic functions, and these other players remain unidentified. Therefore, the goals of the project are to 1) determine the regulation of signaling pathways by Tyr nitration in general, and Tyr nitrated Hsp90 in particular; and 2) identify the specific nitrated protein(s) that support NF2 tumor cell survival, providing a wealth of novel information and opening the door to the development of new therapies for NF2 treatment.\n\n## Tables for Curation\n1. ID: syn31802704\nName: Trial Run HscWT and Hsc45 Proteomics\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Isabelle Logan\n- Example files present: Hsc_Proteomics_Trial01.xlsx, Hsc_PhosphoProteomics_Trial01.xlsx\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn11374354","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374354\n\n###A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings\n&nbsp;\n####**PI:**  Alice Soragni\n**[Soragni Lab at UCLA](http://www.soragnilab.com/)**\n####**cNF Organoid Project**  \nGiven the absence of therapeutic options and the heterogeneous nature of cutaneous neurofibromas (cNF), a physiological system that supports the growth of cNF tumor cells is required for drug screening efforts. To date, surgical removal or laser desiccation are the only treatment options, but can result in scarring and the leave a potential for regrowth.\nTo support drug discovery efforts focused on identifying effective systemic therapies for cNF, we introduce an approach to routinely establish and screen cNF tumor organoids. We optimized conditions to support ex vivo growth of genomically-diverse cNFs. Patient-derived cNF organoids closely recapitulate the molecular and cellular heterogeneity of these tumors as measured by immunohistopathology, DNA methylation, RNA-seq and flow cytometry. Lastly, we have adapted our high-throughput 3D mini-ring approach to screen cNF organoids. Our tractable patient-derived cNF organoid platform enables rapid screening of hundreds of compounds in a patient- and tumor-specific manner.\n\n#### Manuscript\n${buttonlink?text=Link to our published paper&url=https://www.cell.com/cell-reports-methods/fulltext/S2667-2375(24)00116-4&highlight=true&align=None}\n\n#### Data Access\nTo download the files, access the links in the table below:\n\nData Type | Dataset  | Metadata\n--- | --- | -- \nRNASeq | syn45172099 | syn57257803\nRRBS | syn45172461 | syn57257804\nNF1 Mutations | syn25831644\n\nData can be easily browsed with metadata on the [NF Data Portal](http://nfdataportal.org).  The cNF Organoid Project and all of its information can be found [here](https://nf.synapse.org/Explore/Studies/DetailsPage/Files?studyId=syn11374354). \n\n\nAll data files, results,  and associated metadata (that align with NF Data portal standards) can be programmatically queried, browsed, and downloaded from the [project metadata](syn11601495) table. We included a summary of data below:\n\n${synapsetable?query=select id%2Cname%2CdataType%2CindividualID%2Csex%2Cage%2CfileFormat%2CcreatedOn from syn11601495 where individualID is not NULL order by createdOn desc &showquery=true&tableonly=false}\n\n\n### Analysis code to reproduce results\n\nAll code to generate preliminary figures can be found [on GitHub](https://github.com/PNNL-CompBio/cNFOrganoidAnalysis). \n\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n\n## Tables for Curation\n1. ID: syn64954761\nName: 12 months deliverable\nSummary:\n- Assays: immunohistochemistry\n- Species: Homo sapiens, \n- Individual count: 9\n- Specimen count: 76\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: image, \n- File formats present: tif, doc, jpg, pdf\n- Funders: NTAP\n- Contains data created by: Alice Soragni\n- Example files present: PT.2.9.S100.40X.tif, PT2.9.CD34.40X.tif, PT2.9.CD56.20X.tif, PT2.9.CD56.40X.tif, PT2.9.S100.20X.tif\n\n\n\n2. ID: syn64954762\nName: 6 month deliverables\nSummary:\n- Assays: immunohistochemistry\n- Species: Homo sapiens\n- Individual count: 1\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: image, \n- File formats present: pdf, powerpoint, jpg\n- Funders: NTAP\n- Contains data created by: Alice Soragni\n- Example files present: Human CD56 IHC Staining Protocol.pdf, Human SOX10 IHC Staining Protocol.pdf, Human SOX2 IHC Staining Protocol.pdf, Human NGFR IHC Protocol.pdf, Human S100 IHC Protocol.pdf\n\n\n\n3. ID: syn61847288\nName: Aligned reads from RNA-seq of cutaneous neurofibroma organoid model\nSummary:\n- Assays: RNA-seq\n- Species: , Homo sapiens\n- Individual count: 5\n- Specimen count: 54\n- Diagnoses present: , Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: dataIndex, AlignedReads\n- File formats present: bai, bam\n- Funders: ?\n- Contains data created by: Orca Service\n- Example files present: 1_S1_L001.markdup.sorted.bam.bai, 1_S1_L001.markdup.sorted.bam, 10_S10_L001.markdup.sorted.bam.bai, 10_S10_L003.markdup.sorted.bam.bai, 10_S10_L002.markdup.sorted.bam.bai\n\n\n\n4. ID: syn61847298\nName: Gene expression quantification of cutaneous neurofibroma organoid model\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 55\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: Orca Service\n- Example files present: quant.sf, quant.genes.sf, quant.genes.sf, quant.sf, quant.sf\n\n\n\n5. ID: syn45172461\nName: NF Organoid Bisulfite-seq\nSummary:\n- Assays: bisulfite sequencing, bisulfiteSeq, RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 55\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: chromatinActivity\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: NF0002-8-19--D-plus-C_S46_L003_R2_001.fastq.gz, NF0002-8-19--D-plus-C_S46_L003_R1_001.fastq.gz, NF0002-8-19--M--Mammo_S42_L003_R2_001.fastq.gz, NF0002-8-19--D--DMEM_S45_L003_R2_001.fastq.gz, NF0002-8-19--M--Mammo_S42_L003_R1_001.fastq.gz\n\n\n\n6. ID: syn45172099\nName: NF Organoid RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 57\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: ?\n- Example files present: 1_S1_L003_R1_001.fastq.gz, 1_S1_L001_R1_001.fastq.gz, 1_S1_L001_R2_001.fastq.gz, 1_S1_L002_R2_001.fastq.gz, 1_S1_L003_R2_001.fastq.gz\n\n\n\n7. ID: syn51198895\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 5\n- Specimen count: 57\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Alice Soragni\n- Example files present: 1_S1_L003_R1_001.fastq.gz, 1_S1_L001_R1_001.fastq.gz, 1_S1_L001_R2_001.fastq.gz, 1_S1_L002_R2_001.fastq.gz, 1_S1_L003_R2_001.fastq.gz\n\n\n\n8. ID: syn64954763\nName: RNASeq - Failed QC\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens\n- Individual count: 2\n- Specimen count: 6\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq, sf\n- Funders: NTAP\n- Contains data created by: Alice Soragni, Sara Gosline\n- Example files present: 44_S44_L001_R1_001.fastq.gz, 44_S44_L001_R2_001.fastq.gz, 44_S44_L002_R1_001.fastq.gz, 44_S44_L002_R2_001.fastq.gz, 44_S44_L003_R1_001.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn28545963","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn28545963\n\n\n${image?fileName=SchwannomatosisOpenResearchCollaborativeBanner%2DV1%2DR1%2D4x%2Epng&align=Center&scale=100&responsive=true&altText=}\n# Welcome!\n**Schwannomatosis** (SWN) is a rare, understudied genetic disorder that predisposes individuals to the development of nerve sheath tumors. While SWN is in some cases caused by germline mutations in the SMARCB1 and LZTR1 genes, the genomic landscape and genetic modifiers of this disorder are poorly understood. Recent efforts to study the genomics of SWN patients have increased our understanding of the disorder, and much of the data from this research is now publicly available. With support from the Children's Tumor Foundation, we have developed the **Schwannomatosis Open Research Collaborative (SORC)**, a community-based research project with the goal of utilizing public data to uncover new scientific insights into SWN.\n\n#  Objectives\n\nThe primary objective of this project is to perform comprehensive genomic analyses to uncover **noncoding variants**, **coding variants in under-studied genes**, or other genomic features that contribute to disease etiology and heterogeneity in SWN, including SMARCB1-related SWN, LZTR1-SWN, 22q-related SWN, SWN-not otherwise specified, and NF2-related SWN. Our secondary objective is to expand the NF communityâ€™s capacity for computational research.\n\n#  Apply for a SORC Computational Partnership to get help analyzing your SWN data\n**UPDATE MARCH 2024:** We are excited to launch the **SORC Computational Partnership Initiative**, in which we will work with selected researchers to design and complete genomic analyses, providing the necessary genomics expertise and computational resources.\n\n**To be eligible for this initiative, applicants must:**\n-have data available at the launch of the partnership, either directly from the researcher or through publicly available data repositories\n-have a specific question they are trying to answer or an analysis they are trying to perform\n-agree to complete a data sharing plan and share data used in the analyses through the [NF data portal](https://nf.synapse.org/) at the conclusion of the project or upon publication of a relevant manuscript\n-co-author a [micropublication](https://sagebionetworks.pubpub.org/) describing the partnership effort\n\nApplicants should develop an **outline of the proposed analysis** they are hoping to perform or the biological question they would like to answer using the available data. Interested researchers should set up a meeting with SORC leadership for an informal, preliminary discussion to brainstorm and refine analysis ideas. Upon completion of analyses, SORC will provide a written report with all necessary information that can be included in a relevant publication. Our capacity is limited, so we will prioritize projects based on feasibility which will be evaluated on a first-come first-serve basis. Priority will also be given to projects focused on rarer classifications of SWN.\n\n**To apply:**\nPlease [email us at nf-osi@sagebionetworks.org](mailto:nf-osi@sagebionetworks.org) with the subject line â€œSORC Computational Partnership Proposalâ€ and provide an **outline of your proposed analysis**. We will then set up an informal meeting to discuss your analysis needs or ideas.\n\n\n# Available Data and Data Access\n${image?fileName=SWNTS%5Fdata%5Fprocessing%5Fschematic%2Epng&align=right&scale=35&responsive=true&altText=}\nThis project utilizes data from the [Synodos for Schwannomatosis initiative](https://nf.synapse.org/Explore/Studies/DetailsPage?studyId=syn9727752).  We have reprocessed available genomic data using standardized pipelines from [nf-core](https://nf-co.re/).  \n\nProcessed data such as variant calls and gene counts are available to project participants\nTo access the files, a user must:\n1. [Create a Synapse account](https://www.synapse.org/#!RegisterAccount:0). \n2. [Take the Synapse certification quiz](https://www.synapse.org/#!Quiz:Certification).\n3. [Fill in your user profile](https://www.synapse.org/#!Profile:v/profile). At a minimum, first name, last name, current affiliation and [ORCID](https://orcid.org/) are  required.\n4. Processed data files can be found [here](https://www.synapse.org/#!Synapse:syn9727752/files/). Click on the file you wish to access and then click the ***Request Access*** button.\n5. Accept the Terms and Conditions of Use for Synodos Schwannomatosis Data\n\n# Join us! Propose or contribute to an analysis\n\nIf you would like to join this collaborative effort, please fill out the registration form linked below. This will insure that you receive proper credit for your contributions in publications and any other materials produced as a result of this project. Contributions to this project should be made through the [GitLab repository](https://gitlab.com/nf-community/swnts/). If you have any other questions about this project or accessing the data, please email [nf-osi@sagebionetworks.org](mailto:nf-osi@sagebionetworks.org).\n\n${buttonlink?text=Registration Form&url=https://docs%2Egoogle%2Ecom/forms/d/e/1FAIpQLSd%2DlL6x2ub5LAjbzsK1469KWca6qhSEA24lMUJ%5FQkCxdeSEOA/viewform%3Fusp%3Dsf%5Flink&align=center}\n\n\n## Analyses\n\nAll code and results from project analyses will be maintained through the project [GitLab Repository](https://gitlab.com/nf-community/swnts/). \n\n### Proposed analyses\n\nSeveral analyses have already been proposed, and can be found on the [issues](https://gitlab.com/nf-community/swnts/-/issues) GitLab page. Proposed analyses include genome-wide variant interpretation and prioritization, transcript analyses to identify novel splice variants or gene fusions in schwannomas, analyses that integrate multiple data types to identify genes or biological pathways of interest, and machine learning analyses trained on larger cancer datasets in order to identify novel biological processes or disrupted patterns that are important in schwannomatosis.\n${image?fileName=SWNTS%5Fproposed%5Fanalyses%2Epng&align=center&scale=35&responsive=true&altText=}\n\n### Ideas for new analyses\nIf you have an idea for an analysis you would like to see utilizing this data, you can submit that idea to the project [GitLab page](https://gitlab.com/nf-community/swnts/-/issues/new).\n\n\n\n\n\n\n\n\n\n\n\n\n## Tables for Curation\n1. ID: syn44195326\nName: Viral Counts (CTAT-VIF)\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: swn_patient_10_tumor_109.VirusDetect.virus_read_counts_summary.tsv, swn_patient_10_tumor_110.VirusDetect.virus_read_counts_summary.tsv, swn_patient_10_tumor_111.VirusDetect.virus_read_counts_summary.tsv, swn_patient_10_tumor_112.VirusDetect.virus_read_counts_summary.tsv, swn_patient_17_tumor_31.VirusDetect.virus_read_counts_summary.tsv\n\n\n\n2. ID: syn32354801\nName: WES\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: \n- Example files present: \n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn4939892","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939892\n\n##Identification of Neurofibroma Growth and Drug Resistance Pathways\n**Initiative:** Open\n&nbsp;\n**Name:** Nancy Ratner, Ph.D.\n**Contact Email:** nancy.ratner@cchmc.org\n**Dates:** 2-1-14 to 1-31-16\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Biomarkers, Omics\n&nbsp;\n**Background:** Up to 50%>  of children  with NF1 develop plexiform  neurofibromas  that can cause severe disfigurement  and serious morbidity-- and death when they compress vital organs.  Most plexiform neurofibromas are resistant to chemotherapy and surgical removal is often impossible due to tumor size, location, and nerve integration.  We jo not know why some  human neurofibromas  grow slowly and some rapidly,  nor why some neurofibromas respond to therapy but others do not.  Plexiform neurofibromas grow most aggressively in young children, and an appealing (unproven) idea is that transiently blocking growth of plexiform neurofibromas early in tumor development  will prevent  tumor progression.   Models  to study these critical issues have been lacking.   Our laboratory  has recently  developed  mouse models  that recapitulate  1) slow  and fast growing neurofibromas, and 2) neurofibromas that respond or fail to respond to targeted molecular therapy.   We plan to use new methods in gene expression  analysis to identify molecular  pathways  that correlate with these phenotypes  in mouse models, with verification on human tissues.   We also plan test if early treatment delays or halts neurofibroma formation by administering drugs before tumors develop in a neurofibroma mouse model\n&nbsp;\n**Goals of Project:** To identify tumor markers that serve as biomarkers in NF growth and tumors that are resistant to therapy\n&nbsp;\n**Impact:** \nThe work proposed in Aim 1A is expected to identify biomarkers of slow versus fast growing tumors. For example, we might find that fast growing tumors express a secreted factor predicted to be detected in serum or urine. In addition, we might identify targets which, when blocked, can slow the growth of rapidly growing plexiform neurofibromas. Identified markers can be analyzed in human tissues.  The work proposed in Aim 1B is expected to identify pathways that can be targeted to reduce growth of or kill neurofibroma cells. Thus, if we identify genes with high expression in tumors that fail to respond to a drug, we will co-target that pathway with the given drug (e.g. MEKi). If this succeeds in mice, we will test for expression of the gene/pathway in human tissue samples. Thus, we are defining cells and targets to use in clinical trials of plexiform neurofibroma.\n&nbsp;\n**Publications:** We will include the Stat genes in a paper that we are beginning to write now, with our MEK/Stat preclinical therapeutics. We will publish the MEK Resistance story after we carry out the preclinical test which we have planned. We will publish the fast versus slow growing tumors if and when we verify that one or more differentially regulated genes have a role in tumor growth.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn65467784\nName: Gene Expression for Identification of Neurofibroma Growth and Drug Resistance Pathways\nSummary:\n- Assays: RNA-seq, \n- Species: Mus musculus, \n- Individual count: 2\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma, \n- Data types: geneExpression, \n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Kwangmn Choi\n- Example files present: DESeq2-PD0325901_all-vs-control-featureCounts-noFilter-output.xls, DESeq2-PD0325901_R-vs-PD0325901_NR-featureCounts-noFilter-output.xls, edgeR-PD0325901_all-vs-control-featureCounts-noFilter-output.xls, edgeR-PD0325901_R-vs-PD0325901_NR-featureCounts-noFilter-output.xls, Voom-PD0325901_all-vs-control-featureCounts-noFilter-output.xls\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn51133946","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn51133946\n\n${buttonlink?text=DHART SPORE Home Page&url=https://www%2Esynapse%2Eorg/#!Synapse:syn5666132/wiki/&highlight=true&align=None}\n\n# DHART SPORE Project 3 Phase 1 - A High Content Clinical Trial of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML)\n## NIH-NCI - Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence\n### Principal Investigator: Kevin Shannon, Mignon Loh\n### Project Lead / Data Coordinator: Kevin Shannon, Mignon Loh\n### Institution: University of California, San Francisco\n### Project Description:\nChildren with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML), an aggressive myeloproliferative neoplasm (MPN) that responds poorly to chemotherapy. Hematopoietic stem cell transplantation (HSCT) cures ~50% of patients. Our studies of JMML specimens proved that NF1 functions as a tumor suppressor gene in hematopoietic cells, and provided the first direct evidence of deregulated Ras signaling in primary cancer cells from NF1 patients. These studies support the role of hyperactive Ras signaling in JMML pathogenesis, and our group and other researchers subsequently discovered mutations in NRAS, KRAS, PTPN11, and CBL in JMML patient specimens. Overall, >85% of JMML cases have mutations in one of these genes, including 15-20% with clinical NF1 or mutations in the NF1 gene. Despite the routine use of HSCT, up to 30% of JMML patients progress to acute myeloid leukemia (AML). Consistent with the molecular genetics of JMML, using the Mx1-Cre transgene to inactivate the conditional mutant Nf1flox allele generated by the Parada lab or to express oncogenic KrasG12D or NrasG12D in the hematopoietic compartment induces a JMML-like MPN in mice. Preclinical trials in these accurate GEM models revealed remarkable efficacy of MEK inhibitors. Importantly, however, this, treatment does not eradicate mutant bone marrow cells, but modulates their proliferation and differentiation in vivo. The overall goals of Project 3 are to translate these promising preclinical data in JMML patients though an innovative clinical trial that includes deep molecular analysis.\n\n## Tables for Curation\n1. ID: syn54700333\nName: ADVL1521 Omic Data Repository\nSummary:\n- Assays: single-cell RNA-seq\n- Species: Homo sapiens\n- Individual count: 7\n- Specimen count: 14\n- Diagnoses present: ?\n- Tumor types present: Juvenile Myelomonocytic Leukemia\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NIH-NCI\n- Contains data created by: ?\n- Example files present: UPN3037_HM5230_Pre_S6_L003_I1_001.fastq.gz, UPN3037_HM5230_Pre_S6_L003_I2_001.fastq.gz, UPN3037_HM5230_Pre_S6_L003_R1_001.fastq.gz, UPN3037_HM5230_Pre_S6_L003_R2_001.fastq.gz, UPN3037_HM5230_Pre_S6_L004_I1_001.fastq.gz\n\n\n"}],"max_tokens":6000}}
{"custom_id":"syn4939918","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939918\n\n##Using PNF-derived NF1(+/-) and NF1 (-/-) iPS Cells: Understanding PNF-cell of Origin, First Steps in Malignant Progression and Specific Inhibition of NF1 (-/-) Cell Proliferation\n**Initiative:** Open\n&nbsp;\n**Name:** Edu Serra \n**Contact Email:** eserra@igtp.cat\n**Dates:** 12-1-15 to 5-31-18\n**Tumor Focus:** plexiform neurofibroma\n**Application:** Cell Culture\n&nbsp;\n**Background:** In order to identify effective drugs against plexiform neurofibroma (PNF) formation/ progression we need to test them in the right in vitro and in vivo model systems. This involves, among other things, being able to use large quantities of NF1(+/-) and (-/-) cells closely resembling cells driving PNF formation and growth. PNF-derived NF1(+/-) and (-/-) iPS cells have been generated and can be used to test differentiation protocols towards the Neural Crest (NC) -Schwann cell (SC) lineage. Differentiated cells at different points of this lineage commitment can be characterized and engrafted into the sciatic nerve of nude mice to test their tumor-formation capacity and, in this way, interrogate about the identity of the cells originating PNFs. Two things, the setting up the right in vitro iPSC differentiation conditions towards NC and SC in one side and on the other, the characterization of the different steps of differentiation in the NC-SC lineage, will proportionate the basis for performing future drug screenings for PNFs using iPSC-derived cells.\n&nbsp;\n**Goals & Aims:** \nâ€¢\tTo set up in vitro conditions to efficiently differentiate iPS cells into cells of the Neural Crest -Schwann cell lineage. Characterize the methylome and transcriptome of these cells with distinct NF1 genotypes and test their potential engraftment/tumor formation capacity.\nâ€¢\tGenerate new iPSC and edit control iPSC with distinct NF1 genotypes to interrogate the presence of epigenetic memory in the PNF-derived iPS cells generated\n&nbsp; \n**Publications/Posters/Presentations:** Two manuscripts are being written. \nIn one manuscript the intra-PNF variability concerning histology and genomics is described. A correlation between histological and genomic findings is presented. All PNFs used for the iPSC generation were included.\nIn a second manuscript the generation, characterization and use of the PNF-derived NF1(+/-) and NF1(-/-) cell lines is fully described. These cell lines are being deposited in a stem cell bank to give access to interested NF1 researchers.\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn51930713\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: ?\n- Individual count: 4\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: quant.sf, quant.sf, quant.genes.sf, quant.genes.sf, quant.genes.sf\n\n\n\n2. ID: syn64954688\nName: MethylationArray\nSummary:\n- Assays: methylation array, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: chromatinActivity, \n- File formats present: idat, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Kaitlin Throgmorton\n- Example files present: 202915420028_R07C01_Grn.idat, 202908420087_R05C01_Grn.idat, 202915420028_R01C01_Red.idat, 202908420087_R04C01_Grn.idat, 202908540037_R04C01_Grn.idat\n\n\n\n3. ID: syn51198953\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 4\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno\n- Example files present: EX16_FiPS_NC_1.fastq.gz, FiPS_PSC_2.fastq.gz, 5PNF_TDiPSsv_MM_PSC_1.fastq.gz, 3PNF_SiPSsv_MM_PSC_1.fastq.gz, EXP13_EXP14_3PNFiPS_5PNFiPS_14_2.fastq.gz\n\n\n\n4. ID: syn64954689\nName: RNAseq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 4\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: Not Applicable, \n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Christina Parry\n- Example files present: EX16_FiPS_NC_1.fastq.gz, FiPS_PSC_2.fastq.gz, 5PNF_TDiPSsv_MM_PSC_1.fastq.gz, 3PNF_SiPSsv_MM_PSC_1.fastq.gz, EXP13_EXP14_3PNFiPS_5PNFiPS_14_2.fastq.gz\n\n\n\n5. ID: syn64954690\nName: SNParray\nSummary:\n- Assays: SNP array, \n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: genomicVariants, \n- File formats present: txt, \n- Funders: NTAP\n- Contains data created by: Bernat Gel Moreno, Kaitlin Throgmorton\n- Example files present: PNF13_S.txt, PNF13_FiPS_PM_5.txt, PNF13_SiPS_PM_4.txt, PNF13.txt, PNF13_F.txt\n\n\n"}],"max_tokens":6000}}
